Health Policy Snapshot: May 2024

Health Policy Snapshot: May 2024

Biosecure Act to receive vote in House committee; Biopharma and biotech companies scramble to assess potential impact The House Oversight Committee will mark up a far-reaching bill on May 15 that, if passed, could force many US biopharma companies to cut ties with...
Health Policy Snapshot: May 2024

Health Policy Snapshot: February 2023

CMS Issues Guidance on How to Handle Prescription Drug Prices that Increase Higher than Inflation The 2022 Inflation Reduction Act (IRA), touted several times by President Biden in last week’s “State of the Union” address, requires prescription drug companies to pay...